NASDAQ:PACB

Pacific Biosciences Of California Stock News

etoro logo Buy PACB
*Your capital is at risk
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
MENLO PARK, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- PacBio announced today that its executives will be speaking at the following investor conferences:
Pacific Biosciences of California Inc (NASDAQ: PACB) reported Q3 sales of $34.9 million, beating the consensus of $33.23 million and up 83% Y/Y.  The company placed 44 Sequel II or IIe instruments
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q3 2021 Results - Earnings Call Transcript
The genomic revolution is upon us and these stocks could be great vehicles for investors who want to take advantage of it.
Investing gets simple if you have to put all of your eggs in one basket.
MENLO PARK, Calif., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality seque
PacBio's (PACB) latest acquisition is expected to deliver a differentiated set of products and applications across a wide spectrum of markets.
MENLO PARK, Calif., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences
Have penny stocks presented some of the biggest opportunities in the stock market? The post Are Penny Stocks Worth It?
PacBio (PACB) sees strength in Q2 product revenues, led by robust consumable sales.
Pacific Biosciences: Boom In Genome Sequencing Technology With 35% Upside
Pacific Biosciences of California Inc (NASDAQ: PACB), after the close of the market on Tuesday, reported Q2 sales of $30.6 million, beating the consensus of $29.9 million and up 79% Y/Y.  The Compa
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q2 2021 Results - Earnings Call Transcript
Pacific Biosciences (PACB) delivered earnings and revenue surprises of -5.00% and 0.49%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2021.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE